Voyager Therapeutics, Inc. (VYGR) stock
VYGRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3042% below fair value
$1.70−0.06 (-3.41%)
Close on Nov 12, 2026Market cap $104.75MP/E –Yield –
Voyager Therapeutics statistics
79 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Q3 FY2026, expected soon
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 0.78
- 2.29
Enterprise valuationIndustry
- EV / Sales
- -1.09
- 2.60
Share statisticsIndustry
- Shares Change (YoY)
- 3.00%
- 10.9%
- Shares Change (QoQ)
- 1.47%
- 0.51%
- Float
- 60M
- 49M
- Shares Held by Insiders
- 2.59%
- 12.1%
- Shares Held by Institutions
- 56.9%
- 56.4%
Short sellingIndustry
- Short Interest
- 4M
- –
- Short Interest Change
- 20.3%
- -0.76%
- Short % of Float
- 7.29%
- 9.04%
- Short % of Shares Outstanding
- 7.10%
- 6.30%
- Days to Cover
- 4.10
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $5.48
- –
- 52-Week Low
- $1.67
- –
- 20-Day Moving Average
- $1.84
- –
- 50-Day Moving Average
- $2.41
- –
- 200-Day Moving Average
- $3.36
- –
- Average True Range (14)
- $0.15
- –
- Price Change (1 Week)
- -1.16%
- 1.51%
- Price Change (1 Month)
- -15.4%
- -2.35%
- Price Change (3 Months)
- -48.0%
- -21.1%
- Price Change (6 Months)
- -59.9%
- -22.6%
- Price Change (YTD)
- -56.7%
- -22.6%
- Price Change (1 Year)
- -60.1%
- -20.7%
- Price Change (3 Years)
- -72.9%
- -27.4%
- Price Change (5 Years)
- -49.7%
- -77.3%
- Price Change (10 Years)
- -86.1%
- -62.7%
- Average Volume (10 Days)
- 1M
- –
- Average Volume (20 Days)
- 1M
- –
- Average Volume (90 Days)
- 703,261
- –
- Relative Volume
- 2.00
- 0.79
- Relative Strength Index (14)
- 37.2
- 44.7
- Volatility (1 Year)
- 61.5%
- 80.4%
- Beta (5 Years)
- 1.18
- 1.07
MarginsIndustry
- Pretax Margin
- -416.1%
- -11.8%
- EBITDA Margin
- -450.1%
- -27.7%
- FCF Margin
- -437.4%
- -9.20%
Returns on capitalIndustry
- Return on Equity (ROE)
- -58.9%
- -51.2%
- Return on Assets (ROA)
- -44.9%
- -40.6%
- Return on Capital Employed (ROCE)
- -70.5%
- -38.0%
Financial positionIndustry
- Current Ratio
- 6.81
- 3.30
- Quick Ratio
- 8.10
- 2.42
GrowthIndustry
- Revenue Growth (YoY)
- -19.8%
- 7.01%
- Revenue Growth (3Y CAGR)
- -0.44%
- 2.25%
- Revenue Growth (5Y CAGR)
- -25.1%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.11
- 0.40
- Revenue Per Employee
- $178.07K
- $429.29K
- Profits Per Employee
- -$741.35K
- -$683.67K
- Employee Count
- 141
- 75
- WACC
- 10.9%
- 10.1%
Income statement (TTM)Industry
- Pretax Income
- -$104.47M
- -$13.23M
Balance sheetIndustry
- Net Cash (Debt)
- $132.10M
- $17.46M
- Net Cash Per Share
- $2.14
- $0.72
- Equity (Book Value)
- $135.11M
- $53.27M
- Book Value Per Share
- $2.19
- $1.50
- Tangible Book Value
- $135.11M
- $26.82M
- Working Capital
- $97.62M
- $79.47M
Cash flow (TTM)Industry
- Capital Expenditures
- -$640.00K
- -$944.00K
- FCF Per Share
- -$1.78
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -99.8%
- -20.8%
- FCF Yield
- -104.8%
- -9.58%
Taxes and interestIndustry
- Income Tax
- $61.00K
- $74.00K
Scores and fair valueIndustry
- Altman Z-Score
- -3.94
- 0.30
- Piotroski F-Score
- 2
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | VYGR | S&P 500 | Difference | VYGR per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -25.1% | -2.7% | −22.4 pts | ||
| 3 months | -46.9% | -1.7% | −45.1 pts | ||
| Year to date | -56.7% | +11.9% | −68.6 pts | ||
| 1 year | -60.0% | +12.0% | −72.0 pts | ||
| 3 years | -73.2% | +78.2% | −151.4 pts | -35.5% | +21.2% |
| 5 years | -49.7% | +73.2% | −122.9 pts | -12.8% | +11.6% |
| 10 years | -86.1% | +309.6% | −395.8 pts | -17.9% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
4M VYGR shares were sold short on Oct 30, 2026, up 20.3% from the previous report, or 7.29% of the shares available to trade. At recent volumes it would take 4.1 days to buy them back. Over the last 20 sessions, 58.4% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 4,377,124 | +20.3% | 1,067,399 | 4.1 |
| Oct 15, 2026 | 3,638,416 | -8.4% | 906,539 | 4.0 |
| Sep 30, 2026 | 3,973,207 | +8.7% | 618,059 | 6.4 |
| Sep 15, 2026 | 3,655,802 | -3.4% | 424,491 | 8.6 |
| Aug 31, 2026 | 3,785,882 | -4.0% | 426,555 | 8.9 |
| Aug 14, 2026 | 3,945,546 | +8.3% | 447,812 | 8.8 |
| Jul 31, 2026 | 3,643,765 | -5.0% | 623,344 | 5.8 |
| Jul 15, 2026 | 3,837,218 | +7.3% | 838,985 | 4.6 |
| Jun 30, 2026 | 3,574,789 | -2.0% | 698,113 | 5.1 |
| Jun 15, 2026 | 3,647,445 | -2.6% | 502,890 | 7.3 |
| May 29, 2026 | 3,744,360 | +7.9% | 614,841 | 6.1 |
| May 15, 2026 | 3,471,109 | -5.2% | 540,870 | 6.4 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?